| Literature DB >> 21279449 |
Athanasios D Anastasilakis1, Gregory A Kaltsas, Georgios Delimpasis, Ludwig Wilkens, George Kanakis, Polyzois Makras.
Abstract
We present a 22-year old male patient previously treated with radiotherapy and surgery at the age of 7 for an undefined suprachiasmatic mass. Following treatment he gradually became morbidly obese and besides subsequent panhypopituitarism he achieved his target height probably due to obesity-induced severe hyperinsulinemia. At the age of 21 Langerhans' cell histiocytosis was diagnosed at the right mandible and was surgically treated. One year later he developed a further painful osteolytic hip lesion and a single zoledronate infusion eliminated all symptoms. We highlight the importance of obtaining a histological diagnosis before initiating treatment, and the distinctive course of the disease in a patient who continued to growth besides GH deficiency.Entities:
Mesh:
Year: 2012 PMID: 21279449 DOI: 10.1007/s11102-011-0291-6
Source DB: PubMed Journal: Pituitary ISSN: 1386-341X Impact factor: 4.107